AI Verdict
PAHC has stronger fundamentals based on our AI analysis.
PAMT vs PAHC Fundamental Comparison
| Metric | PAMT | PAHC |
|---|---|---|
| Revenue | $598.1M | $737.8M |
| Net Income | $-52.6M | $54.0M |
| Net Margin | -8.8% | 7.3% |
| ROE | -25.0% | 16.2% |
| ROA | -7.5% | 3.8% |
| Current Ratio | 1.23x | 3.05x |
| Debt/Equity | 1.59x | 1.88x |
| EPS | $-2.48 | $1.32 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PAMT vs PAHC: Frequently Asked Questions
Is PAMT or PAHC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), PAHC has stronger fundamentals. PAMT is rated STRONG SELL (95% confidence) while PAHC is rated HOLD (62% confidence). This is not investment advice.
How does PAMT compare to PAHC fundamentally?
PAMT CORP has ROE of -25.0% vs PHIBRO ANIMAL HEALTH CORP's 16.2%. Net margins are -8.8% vs 7.3% respectively.
Which stock pays higher dividends, PAMT or PAHC?
PAMT has a dividend yield of N/A or no dividend while PAHC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PAMT or PAHC for long term?
For long-term investing, consider that PAMT has STRONG SELL rating with 95% confidence, while PAHC has HOLD rating with 62% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PAMT vs PAHC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PAMT vs PAHC, the AI consensus favors PAHC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.